Zhujiang Hospital of Southern Medical University
Guangzhou, Guangdong, 510280, China
Location status: Recruiting
Recruiting
NCT Number: NCT05187000
Effects of Individualized rTMS in DOC Patients
Background: Disorder of consciousness(DOC) is a series of arousal and cognitive disorders secondary to the most severe brain injury. Once a patient is diagnosed with a DOC, a poor prognosis is assumed and the rehabilitation for whom is greatly limited. Therefore, the treatment of DOC poses extraordinary challenges. Various treatments protocols have been reported of successful in promoting rehabilitation of DOC patients. Repetitive transcranial magnetic stimulation(rTMS), as a non-invasive brain stimulation technique, has shown potentials for consciousness rehabilitation of DOC patients as it is effective in regulating the central nervous system.
Methods and design: This protocol is a double-blind randomized sham-controlled crossover trial. Totally 30 participants will be randomly assigned to either group 1 or group 2 in a 1:1 ratio, with 15 patients in each group. Each patient will received 20 sessions, in which 10 sessions will be active and 10 will be sham, separated by 10-days washout period. The active-rTMS will include 10 Hz rTMS over the individual-targeted area on each participants. Primary and secondary evaluating indicators will be performed at each baseline and after rTMS treatment. Primary outcome will be determined as behavioral response to treatment as measured using the Coma Recovery Scale - Revised (CRS-R). Resting-state high-density EEG will be also recorded to investigate the neurophysiological correlates by rTMS.
Discussion:This study will contribute to define the role of rTMS for the treatment of DOC patients and characterise the neural correlates of its action. The investigators proposed a method of individualized target selection for DOC patients based on the existing gold standard CRS-R score and MRI, and used a cross randomized controlled trial to verify the role of rTMS in DOC treatment.
Recruiting
Interested in participating?
Request InfoKey information
Conditions
Age range
18 year–70 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- acquired brain injuries less than 1 year and more than 28 days in DOC;
- clinical diagnosis of DOC Disease;
- no medical history of neuropsychiatric diseases;
- no contraindications for rTMS or EEG, no sedatives in use or other drugs that might interfere with brain stimulation, such as Na+ or Ca2+ channel blockers or NMDA receptor antagonists;
- stable state of disease and vital signs;
- the families of the patients volunteered the patient to participate in the study and provided signed informed consent;
- the integrity of the individualized stimulation target cortex are verified by MRI.
Exclusion criteria
- patients in other non-invasive or invasive neuroregulation trials;
- motor evoked potential (MEP) in M1 region cannot be induced by TMS pulse;
- uncontrolled epilepsy, seizure within 4 weeks before enrollment;
- metallic implant in the skull, pacemaker, craniotomy under the stimulated site, implanted brain device.
Treatment and study plan
individualized repetitive transcranial magnetic stimulation
DeviceDuring the rTMS-active stage, treatment will be given for 10 consecutive sessions (one session daily). The participants will be placed in the semi-reclining position on either a normal chair or a wheelchair and each stimulation session will last 20 minutes with a frequency of 10 Hz (train duration: 1s; inter-train interval: 5s; 200 effective stimulation series; 2000 pulses at 90% of RMT).
Sham repetitive transcranial magnetic stimulation
DeviceThe sham coil will be used which has no magnetic field to send to the cerebral cortex while appearing to be the same shape as the active coil, with good approximation of auditory feedback.
Primary outcomes
-
Change from Baseline JFK Coma Recovery Scale-Revised(CRS-R) for Crossover Study 1
Time frame: immediately after 10 days individualized rTMS session
The Coma Recovery Scale-Revised(CRS-R), a total of 23 points, is widely used to define the level of consciousness and assess neurobehavioral recovery of patients with DOC. It is based on six subscales that assess auditory(4 points), visual(5 points), motor(6 points), motor/speech(3 points), communication(2 points), and arousal processes(3 points). Each item of CRS-R is in good agreement with the diagnostic and differential diagnostic criteria of VS/UWS, MCS and EMCS. The higher scores mean a better outcome.
-
Change from Baseline JFK Coma Recovery Scale-Revised(CRS-R) for Crossover Study 2
Time frame: immediately after Washout period
The Coma Recovery Scale-Revised(CRS-R), a total of 23 points, is widely used to define the level of consciousness and assess neurobehavioral recovery of patients with DOC. It is based on six subscales that assess auditory(4 points), visual(5 points), motor(6 points), motor/speech(3 points), communication(2 points), and arousal processes(3 points). Each item of CRS-R is in good agreement with the diagnostic and differential diagnostic criteria of VS/UWS, MCS and EMCS. The higher scores mean a better outcome.
-
Change from Baseline JFK Coma Recovery Scale-Revised(CRS-R) for Crossover Study 3
Time frame: immediately after 10 days sham rTMS session
The Coma Recovery Scale-Revised(CRS-R), a total of 23 points, is widely used to define the level of consciousness and assess neurobehavioral recovery of patients with DOC. It is based on six subscales that assess auditory(4 points), visual(5 points), motor(6 points), motor/speech(3 points), communication(2 points), and arousal processes(3 points). Each item of CRS-R is in good agreement with the diagnostic and differential diagnostic criteria of VS/UWS, MCS and EMCS. The higher scores mean a better outcome.
Secondary outcomes
-
Change from Baseline Resting-State EEG for Crossover Study 1
Time frame: immediately after 10 days individualized rTMS session
EEG will be acquired from 66 channels with positions of the International 10-20 System for 10 mins. The relative spectral power (RSP) and functional connectivity (FC) of participants will be calculated by the selected artifact-free EEG epochs at five frequency bands: δ (1-4 Hz), θ (4-8 Hz), α (8-13 Hz), β (13-30 Hz), and γ (30-45 Hz). The investigators will compute off-line analysis to calculate RSP and FC.
-
Change from Baseline Resting-State EEG for Crossover Study 2
Time frame: immediately after Washout period
EEG will be acquired from 66 channels with positions of the International 10-20 System for 10 mins. The relative spectral power (RSP) and functional connectivity (FC) of participants will be calculated by the selected artifact-free EEG epochs at five frequency bands: δ (1-4 Hz), θ (4-8 Hz), α (8-13 Hz), β (13-30 Hz), and γ (30-45 Hz). The investigators will compute off-line analysis to calculate RSP and FC.
-
Change from Baseline Resting-State EEG for Crossover Study 3
Time frame: immediately after 10 days sham rTMS session
EEG will be acquired from 66 channels with positions of the International 10-20 System for 10 mins. The relative spectral power (RSP) and functional connectivity (FC) of participants will be calculated by the selected artifact-free EEG epochs at five frequency bands: δ (1-4 Hz), θ (4-8 Hz), α (8-13 Hz), β (13-30 Hz), and γ (30-45 Hz). The investigators will compute off-line analysis to calculate RSP and FC.
Study contacts
Contact information is provided by the study sponsor or research team.
Chengwei Xu, BSc
CONTACT
Qiuyou Xie, PhD
CONTACT
Sponsors and collaborators
Lead sponsor
Qiuyou Xie
Other
Registry information
Official study title
Effect of Individualized Repetitive Transcranial Magnetic Stimulation (rTMS) in Patients With Disorder of Consciousness
Important dates
- Study start
- 2021
- Primary completion
- 2024
- Study completion
- 2025
- First posted
- Jan 11, 2022
- Registry last updated
- Jul 26, 2024
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Recruiting
Combined Whole-brain Structural and Functional MRI for the Prediction of Neurological Recovery After Cardiac Arrest
NCT06617377
Cardiac Arrest, Cardiovascular Diseases
Toulouse, France
View Trial Details
Recruiting
Neurorehabilitation in Patients With Disorders of Consciousness: Multidimensional Ambispective Study on the Impact of Single and Combined Approaches
NCT07385508
Brain Damage, Chronic, Brain Diseases
Messina, Sicily, Italy
View Trial Details
Recruiting
Efficacy and Safety of Cerebrolysin on Prolonged Disorders of Consciousness
NCT04427241
Brain Diseases, Cardiovascular Diseases
Seoul, South Korea
View Trial Details
Recruiting
Study on the Effectiveness and Safety of Temporal Interference Stimulation in Treating Patients With Severe Consciousness Disorders
NCT06896279
Consciousness Disorders, Disorder of Consciousness
Shanghai, Shanghai Municipality, China
View Trial Details